Cook Andrew, Cook Steven, Smith Ian, Weinrauch Patrick
Toowoomba Base Hospital, QLD, Australia.
St. Andrew's War Memorial Hospital, 457 Wickham Terrace, Spring Hill, QLD, Australia.
Adv Orthop. 2014;2014:109378. doi: 10.1155/2014/109378. Epub 2014 Oct 1.
It is standard practice in many institutions to routinely perform preoperative and postoperative haemoglobin level testing in association with hip joint arthroplasty procedures. It is our observation, however, that blood transfusion after uncomplicated primary hip arthroplasty in healthy patients is uncommon and that the decision to proceed with blood transfusion is typically made on clinical grounds. We therefore question the necessity and clinical value of routine perioperative blood testing about the time of hip resurfacing arthroplasty. We present analysis of perioperative blood tests and transfusion rates in 107 patients undertaking unilateral hybrid hip resurfacing arthroplasty by the senior author at a single institution over a three-year period. We conclude that routine perioperative testing of haemoglobin levels for hip resurfacing arthroplasty procedures does not assist in clinical management. We recommend that postoperative blood testing only be considered should the patient demonstrate clinical signs of symptomatic anaemia or if particular clinical circumstances necessitate.
在许多机构中，常规进行术前和术后血红蛋白水平检测以配合髋关节置换手术是标准做法。然而，据我们观察，健康患者在进行无并发症的初次髋关节置换术后输血并不常见，而且输血的决定通常基于临床情况做出。因此，我们质疑在髋关节表面置换手术时进行常规围手术期血液检测的必要性和临床价值。我们对一位资深作者在一家机构三年内为107例患者进行单侧混合髋关节表面置换手术的围手术期血液检测和输血率进行了分析。我们得出结论，髋关节表面置换手术常规围手术期血红蛋白水平检测无助于临床管理。我们建议仅在患者出现症状性贫血的临床体征或特定临床情况需要时才考虑术后血液检测。
